# FDA 483 - Ronald S. Swerdloff, M.D. - May 21, 2014

Source: https://www.keypedia.com/records/483/ronald-s-swerdloff-md/135c3def-dda6-4ff2-8ecf-124c9c05b5ef

> FDA 483 for Ronald S. Swerdloff, M.D. on May 21, 2014. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ronald S. Swerdloff, M.D.
- Inspection Date: 2014-05-21
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Ronald S. Swerdloff, M.D., a clinical investigator in Torrance, CA, revealed significant deficiencies in the conduct of an investigational study. The firm failed to adhere to the investigational plan, resulting in numerous protocol violations. Additionally, the inspection found inadequate and inaccurate case histories and source documents for study subjects.

## Related Officers

- [investigator](https://www.keypedia.com/people/tawny-l-colling/4ce51467-468c-4271-a98d-4b13c15c0812)

Company: https://www.keypedia.com/companies/ronald-s-swerdloff-md/7ec1c56d-c273-45fe-88ee-1be21ca7d879

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6